The AstraZeneca vaccine has a slightly higher risk of a type of blood disorder.





An analysis of more than 2.5 million Scottish adults who received a first dose of the vaccine Oxford-AstraZeneca O Pfizer-BioNTech revealed a small increased risk of an autoimmune bleeding disorder known as’immune thrombocytopenic purpura ‘(ITP) associated with the Oxford-AstraZeneca vaccine.

The research, published today in Nature Medicine, also suggests that there may be evidence of an increased risk of other bleeding and vascular events associated with the Oxford-AstraZeneca vaccine.

These risks are very small and rare, but they are important, they write in their work, although they emphasize that are comparable to other vaccinessuch as hepatitis B, measles, mumps, rubella, or the flu; for example, with these

READ  what they are and why they have retired

Leave a Reply

Your email address will not be published. Required fields are marked *